Vanessa Kennedy, MD
Research Associate
Medicine
School of Medicine

Awards

Show all (6) Hide

• Physician-Scientist Fellow, Chan Zuckerberg Institute, 2021
• Abstract Achievement Award, American Society of Hematology, 2020
• Rachel Perline Award, University of California San Francisco, 2020
• Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award, American Society of Hematology, 2018-2019
• Abstract Achievement Award, American Society of Hematology, 2015
• Gold Humanism Honor Society, Vanderbilt University School of Medicine, 2015

Education & Training

Show all (3) Hide

• Internal Medicine Residency Stanford University Hospital 06/2019
• MD Vanderbilt University School of Medicine 05/2016
• BS Duke University 05/2010

Publications (71)

Top publication keywords:
MastocytosisLeukemia, Myeloid, AcuteHematopoietic Stem Cell TransplantationTransplantation ConditioningLeukemia, Mast-CellMastocytosis, SystemicProtein Kinase InhibitorsDrug Resistance, NeoplasmMaintenance ChemotherapyTransplantation, Homologousfms-Like Tyrosine Kinase 3Immunotherapy, AdoptiveGraft vs Host DiseaseRed-Cell Aplasia, PureProto-Oncogene Proteins c-bcl-2

• Dynamic genetic and nongenetic RAS-pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy.
  Blood 2026 Kennedy VE, Peretz CAC, Walia A, Chyla B, Sun Y, Hill J, Tran E, Koh AD, Ferng T, Pintar S, Jones MF, Popescu B, Lomeli I, Chehab F, Murad N, John A, Roy R, Olshen A, Berryhill CA, Davis C, Angus SP, …
• A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial.
  Nature medicine 2026 Xu J, Mei C, Guan X, Du R, Wu B, Wu D, Li M, Li J, Song Y, Su H, Chen X, Guo Q, Chen H, Sussman JH, Chen GM, Bandyopadhyay S, Pillai V, Lanz TV, Liedtke M, Onel K, Katsumoto TR, Tan K, Yan X, Chien M,…
• CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.
  Nature medicine 2026 DiPersio JF, Koehne G, Shah NN, Bernard L, Suh HC, Koura D, Tamari R, Mushtaq MU, Maakaron J, Rimando J, Kennedy VE, Patel SS, Hudson C, Loken MR, Slapak CA, Lloyd DM, Stanizzi DA, Lee-Sundlov MM, …
• Multiomic Single-Cell Sequencing Identifies BCR::ABL1 as an Acquired Resistance Mechanism in FLT3+ AML.
  European journal of haematology 2026 Kennedy VE, Peretz CAC, Koh A, Tran E, Dhingra D, Gulati S, Sciambi A, Sala-Torra O, Beppu L, Radich JP, Smith CC
• Clonally Distinct FLT3-TKD Mutations in Host and Donor-Derived AML After Double Cord Blood Transplant: A Case Report.
  EJHaem 2026 Rojansky RB, Law LY, Zhang BM, Kennedy VE

Show all (66 more) Hide

• Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.
  Blood cancer journal 2026 Rana MS, Fernandez-Pol S, Jensen A, Hovanky V, Velayati A, Oak JS, Silva O, Ames E, Muffly LS, Sahaf B, Arai S, Kennedy VE, Bharadwaj S, Iberri DJ, Liedtke M, Natkunam Y, Shiraz P, Weng WK, Smith M, …
• Real-world patterns of maintenance therapy after allogeneic transplant in older adults with acute myeloid leukemia: A Medicare cohort study.
  Journal of geriatric oncology 2026 Kennedy VE, Block A, Young C, Nimke D, Kardel P, Pednekar P
• Superior Chronic Graft-versus-Host Disease-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation.
  Transplantation and cellular therapy 2026 Molina A, Bubb QR, Srinagesh HK, Yee R, Arai S, Bharadwaj S, Dahiya S, Elmariah H, Frank M, Hosoya H, Johnston L, Meyer E, Mikkilineni L, Lowsky R, Negrin R, Rezvani A, Shiraz P, Shizuru J, Sidana S, …
• Inclusion as innovation: broadening trial criteria in AML.
  Blood 2026 Kennedy VE, Muffly L
• Holistic evaluation of large language models for medical tasks with MedHELM.
  Nature medicine 2026 Bedi S, Cui H, Fuentes M, Unell A, Wornow M, Banda JM, Kotecha N, Keyes T, Mai Y, Oez M, Qiu H, Jain S, Schettini L, Kashyap M, Fries JA, Swaminathan A, Chung P, Haredasht FN, Lopez I, Aali A, Tse G, …
• Genomics of Acute Myeloid Leukemia at Diagnosis and Remission.
  medRxiv : the preprint server for health sciences 2025 Yu K, Dillon LW, Tettero JM, Gui G, Al-Ali RW, Grunwald MR, Krakow EF, Griffiths EA, Gomez-Arteaga A, Vedula RS, Solh M, Salhotra A, Bejanyan N, Muffly L, Jimenez-Jimenez AM, Drazer MW, Chen YB, Logan…
• Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort.
  Blood cancer journal 2025 Elias S, Brown S, Egini O, Walji M, Homsy S, Velayati A, Devlin S, Ponce DM, Kennedy V, Bharadwaj S, Shiraz P, Jakubowski AA, Papadopoulos EB, Muffly L, Perales MA, Giralt SA, Smith M, Gyurkocza B
• Remission of TP53-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33).
  JCO precision oncology 2025 Koehne G, Mushtaq MU, Muffly LS, Menes M, Azzi J, Bernard L, Cooper B, Kennedy V, Koura D, Maakaron J, Magenau J, McClune B, Patel SS, Rimando JC, Shah NN, Suh HC, Tamari R, Thosar S, Canesin G, Hyzy …
• Real-world treatment adherence and persistence of FLT3 inhibitors as post-alloHCT maintenance therapy in patients with AML in the United States: a cohort study using administrative claims data.
  Leukemia & lymphoma 2025 Kennedy VE, Touya M, Spalding J, Young C, Cao LF, Nimke D, Block A, Pednekar P
• Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia.
  Nature reviews. Clinical oncology 2025 Glaviano A, Weisberg E, Lam HY, Tan DJJ, Innes AJ, Ge Y, Lai CE, Stock W, Glytsou C, Smit L, Yoshida T, Zhang TY, Kennedy VE, Smith BD, Mercher T, de Botton S, Diana P, Konopleva M, Mauro MJ, Griffin …
• Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy.
  Blood advances 2025 Ananth S, Torres NE, Sahaf B, Mikkilineni L, Fernandez-Pol S, Salmi D, Negrin R, Shiraz P, Smith M, Bharadwaj S, Weng WK, Kennedy VE, Dahiya S, Muffly L, Miklos D, Frank MJ, Hosoya H, Sidana S
• Assessing Social Determinants of Health in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT.
  Transplantation and cellular therapy 2025 Espinoza-Gutarra MR, Collins J, Kennedy V, Randall J, Su CT, Banerjee R, Wuliji N, Odstricil-Bobillo S, Amonoo HL, Wood WA, Hamilton B, Sung A, Lee CJ
• Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy.
  Transplantation and cellular therapy 2025 Kennedy VE, Ahmed N, Artz A, Bhatt NS, Custatis R, Espinoza-Gutarra MR, Farhan S, Ferguson RJ, Hamilton B, Katz H, Kelly DL, Knight JM, Lee C, Lin A, Lin R, Mohanraj L, Munshi P, Nawas M, Nelson AM, …
• Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT.
  Transplantation and cellular therapy 2025 Banerjee R, Amonoo HL, Barata A, Bhatt NS, Espinoza-Gutarra MR, Jayani-Kosarzycki RV, Katz H, Kennedy VE, Nawas M, Steineck A, Wanjiku C, Costanzo E, Cusatis RN, Knight JM, Schoemans H, Sidana S, Wood…
• Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT.
  Transplantation and cellular therapy 2025 Farhan S, Kennedy VE, Espinoza-Gutarra MR, Lust H, Bobillo MSO, Lin AY, Olin RL, Lin RJ, Rentscher KE, Taylor MR, Mohanraj L, Wood WA, Murthy HS, Ahmed N, Dueck AC, Phelan R, Kelly DL, Yuen C, Munshi …
• SNACS: a tool for demultiplexing single-cell DNA sequencing data.
  Bioinformatics (Oxford, England) 2025 Kennedy VE, Roy R, Peretz CAC, Koh A, Tran E, Smith CC, Olshen AB
• The improved prognosis of FLT3-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data.
  Haematologica 2025 Schwede M, Rodriguez G, Kennedy VE, Henry S, Wood D, Mannis GN, Majeti R, Chen JH, Bendavid E, Zhang TY
• A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.
  Blood 2024 Srinagesh H, Jackson C, Shiraz P, Jeyakumar N, Hamilton M, Egeler E, Mavroukakis S, Kuo A, Cancilla J, Sahaf B, Agarwal N, Kanegai A, Kramer AM, Arai S, Bharadwaj S, Dahiya S, Hosoya H, Johnston L, …
• Multiomic single cell sequencing identifies stemlike nature of mixed phenotype acute leukemia.
  Nature communications 2024 Peretz CAC, Kennedy VE, Walia A, Delley CL, Koh A, Tran E, Clark IC, Hayford CE, D'Amato C, Xue Y, Fontanez KM, May-Zhang AA, Smithers T, Agam Y, Wang Q, Dai HP, Roy R, Logan AC, Perl AE, Abate A, …
• Hybrid allogeneic bone marrow transplant rescue approach after acute myelogenous leukaemia relapse in a high-risk patient.
  British journal of haematology 2024 Villar-Prados A, Kennedy VE, Meyer EH
• LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.
  Haematologica 2024 Wintering A, Hecht A, Meyer J, Wong EB, Hübner J, Abelson S, Feldman K, Kennedy VE, Peretz CAC, French DL, Maguire JA, Jobaliya C, Vasquez MR, Desai S, Dulman R, Nemecek E, Haines H, Hammad M, El …
• Advancing Readership Needs of the Clinical Cancer Informatics Community.
  JCO clinical cancer informatics 2024 Kennedy VE, Bates BA, Rooney MK
• Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.
  Allergy 2024 Niedoszytko M, Gorska A, Brockow K, Bonadonna P, Lange M, Kluin-Nelemans H, Oude-Elberink H, Sabato V, Shoumariyeh K, von Bubnoff D, Müller S, Illerhaus A, Doubek M, Angelova-Fischer I, Hermine O, …
• CORAL: Expert-Curated Oncology Reports to Advance Language Model Inference.
  NEJM AI 2024 Sushil M, Kennedy VE, Mandair D, Miao BY, Zack T, Butte AJ
• Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab.
  Transplantation and cellular therapy 2024 Kennedy VE, Sahaf B, Wu F, Ehlinger ZJ, Arai S, Miklos DB
• Monoclonal Gammopathy of Anemic Significance? Resolution of Pure Red Cell Aplasia With Daratumumab-Based Therapy.
  The American journal of medicine 2024 Khan O, Prakash S, Chung A, Wong SW, Kennedy VE
• Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
  Leukemia & lymphoma 2024 Gaut D, Oliai C, Boiarsky J, Zhang S, Salhotra A, Azenkot T, Kennedy VE, Khanna V, Olmedo Gutierrez K, Shukla N, Moskoff B, Park G, Afkhami M, Patel A, Jeyakumar D, Mannis G, Logan AC, Jonas BA, …
• FLT3 targeting in the modern era: from clonal selection to combination therapies.
  International journal of hematology 2023 Kennedy VE, Smith CC
• The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib.
  American journal of hematology 2023 Joshi SK, Pittsenbarger J, Kennedy VE, Peretz CAC, Perl AE, Smith CC, Tyner JW, Druker BJ, Traer E
• Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk Stratification.
  bioRxiv : the preprint server for biology 2023 Peretz CAC, Kennedy VE, Walia A, Delley CL, Koh A, Tran E, Clark IC, Hayford CE, D'Amato C, Xue Y, Fontanez KM, Roy R, Logan AC, Perl AE, Abate A, Olshen A, Smith CC
• Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.
  Blood advances 2023 Kennedy VE, Perkins C, Reiter A, Jawhar M, Lübke J, Kluin-Nelemans HC, Shomali W, Langford C, Abuel J, Hermine O, Niedoszytko M, Gorska A, Mital A, Bonadonna P, Zanotti R, Tanasi I, Mattsson M, …
• Microfluidics-free single-cell genomics with templated emulsification.
  Nature biotechnology 2023 Clark IC, Fontanez KM, Meltzer RH, Xue Y, Hayford C, May-Zhang A, D'Amato C, Osman A, Zhang JQ, Hettige P, Ishibashi JSA, Delley CL, Weisgerber DW, Replogle JM, Jost M, Phong KT, Kennedy VE, Peretz …
• Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis.
  Current problems in cancer 2023 Kennedy VE, Natsuhara K, Maringanti SA, Shah ND, Arora S, Wolf J, Martin TG, Aras MA, Chung A, Wong SW
• Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy.
  Blood advances 2022 Thiruvengadam SK, Sheng Y, Huang CY, Bylsma S, Lo M, Kennedy V, Natsuhara K, Martin T, Wolf J, Shah N, Wong SW
• Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia.
  American journal of hematology 2022 Kennedy VE, Hui G, Azenkot T, Gaut D, Wieduwilt MJ, Oliai C, Jonas BA, Mittal V, Logan AC, Muffly LS, Mannis GN
• Geriatric assessment in adults age 50 years and older undergoing autologous hematopoietic cell transplantation for lymphoma.
  Journal of geriatric oncology 2022 Kennedy VE, Huang CY, Kaplan LD, Andreadis C, Ai WZ, Olin RL
• Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent.
  British journal of haematology 2022 On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM
• Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma.
  Blood advances 2021 Kennedy VE, Wong C, Huang CY, Thiruvengadam SK, Wolf J, Martin TG, Shah N, Wong SW
• VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis.
  Blood advances 2021 Kennedy VE, Wong CC, Hong JM, Peng T, Brondfield S, Reilly LM, Cornett P, Leavitt AD
• Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care.
  The Lancet. Haematology 2021 Kennedy VE, Olin RL
• Frontline treatment patterns and outcomes among older adults with acute myeloid leukemia: A population-based analysis in the modern era.
  Cancer 2021 Kennedy VE, Keegan THM, Li Q, Maguire FB, Muffly LS
• Strongyloides Hyperinfection After Immunosuppression in an Immigrant From El Salvador: A Case for Early Diagnosis and Treatment.
  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021 Hoppenfeld MS, Kennedy V, Sheth K, Chang A, Nelson J, Fairchild RM
• Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma.
  Transplantation and cellular therapy 2021 Banerjee R, Marsal J, Huang CY, Lo M, Thiruvengadam SK, Kennedy VE, Arora S, Wolf JL, Martin TG, Wong SW, Shah N
• A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care.
  Clinical lymphoma, myeloma & leukemia 2021 Kennedy VE, Ruiz-Cordero R, Jangam D, Wen KW, Dunavin N, Ohgami RS, Bhargava P, Ai W, Fakhri B
• Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis.
  Theranostics 2021 Kluin-Nelemans HC, Jawhar M, Reiter A, van Anrooij B, Gotlib J, Hartmann K, Illerhaus A, Oude Elberink HNG, Gorska A, Niedoszytko M, Lange M, Scaffidi L, Zanotti R, Bonadonna P, Perkins C, Elena C, …
• FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies.
  Frontiers in oncology 2020 Kennedy VE, Smith CC
• Marked Hyperbilirubinemia-Silent No More!
  The American journal of medicine 2020 Kennedy VE, Leavitt AD, Cornett P
• Late Effects in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia.
  JNCI cancer spectrum 2020 Muffly L, Maguire FB, Li Q, Kennedy V, Keegan TH
• Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.
  Leukemia 2019 Kluin-Nelemans HC, Reiter A, Illerhaus A, van Anrooij B, Hartmann K, Span LFR, Gorska A, Niedoszytko M, Lange M, Scaffidi L, Zanotti R, Bonadonna P, Perkins C, Elena C, Malcovati L, Shoumariyeh K, von…
• MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Jawhar M, Schwaab J, Álvarez-Twose I, Shoumariyeh K, Naumann N, Lübke J, Perkins C, Muñoz-González JI, Meggendorfer M, Kennedy V, Metzgeroth G, Fabarius A, Pfeifer D, Sotlar K, Horny HP, von Bubnoff N…
• Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort.
  Blood advances 2019 Spinner MA, Kennedy VE, Tamaresis JS, Lavori PW, Arai S, Johnston LJ, Meyer EH, Miklos DB, Muffly LS, Negrin RS, Rezvani AR, Shizuru JA, Weng WK, Hoppe RT, Strober S, Lowsky R
• Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience.
  Frontiers in oncology 2019 Sheth V, Kennedy V, de Lavallade H, Mclornan D, Potter V, Engelhardt BG, Savani B, Chinratanalab W, Goodman S, Greer J, Kassim A, York S, Kenyon M, Gandhi S, Kulasekararaj A, Marsh J, Mufti G, …
• Assessment of older adult candidates for allogeneic hematopoietic cell transplantation: updates and remaining questions.
  Expert review of hematology 2019 Kennedy VE, Muffly LS
• Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration.
  American journal of clinical oncology 2018 Mayadev J, Elshaikh MA, Christie A, Nagel C, Kennedy V, Khan N, Lea J, Ghanem A, Miller D, Xie XJ, Folkert M, Albuquerque K
• The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives.
  The journal of allergy and clinical immunology. In practice 2018 Valent P, Oude Elberink JNG, Gorska A, Lange M, Zanotti R, van Anrooij B, Bonifacio M, Bonadonna P, Gleixner KV, Hadzijusufovic E, Perkins C, Hartmann K, Illerhaus A, Merante S, Elena C, Shoumariyeh K…
• Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017 Kennedy VE, Chen H, Savani BN, Greer J, Kassim AA, Engelhardt BG, Goodman S, Sengsayadeth S, Chinratanalab W, Jagasia M
• Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma.
  Journal of hematology & oncology 2017 Epperla N, Ahn KW, Ahmed S, Jagasia M, DiGilio A, Devine SM, Jaglowski S, Kennedy V, Rezvani AR, Smith SM, Sureda A, Fenske TS, Kharfan-Dabaja MA, Armand P, Hamadani M
• Defining the complex phenotype of severe systemic loxoscelism using a large electronic health record cohort.
  PloS one 2017 Robinson JR, Kennedy VE, Doss Y, Bastarache L, Denny J, Warner JL
• Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017 Hamilton BK, Rybicki L, Abounader D, Adekola K, Advani A, Aldoss I, Bachanova V, Bashey A, Brown S, DeLima M, Devine S, Flowers CR, Ganguly S, Jagasia M, Kennedy VE, Kim DDH, McGuirk J, Pullarkat V, …
• Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.
  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2016 Kennedy VE, Savani BN, Greer JP, Kassim AA, Engelhardt BG, Goodman SA, Sengsayadeth S, Chinratanalab W, Jagasia M
• Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist.
  CA: a cancer journal for clinicians 2016 Lindau ST, Abramsohn EM, Baron SR, Florendo J, Haefner HK, Jhingran A, Kennedy V, Krane MK, Kushner DM, McComb J, Merritt DF, Park JE, Siston A, Straub M, Streicher L
• Does adherence to epilepsy quality measures correlate with reduced epilepsy-related adverse hospitalizations? A retrospective experience.
  Epilepsia 2015 Ladner TR, Morgan CD, Pomerantz DJ, Kennedy VE, Azar N, Haas K, Lagrange A, Gallagher M, Singh P, Abou-Khalil BW, Arain AM
• Can you ask? We just did! Assessing sexual function and concerns in patients presenting for initial gynecologic oncology consultation.
  Gynecologic oncology 2015 Kennedy V, Abramsohn E, Makelarski J, Barber R, Wroblewski K, Tenney M, Lee NK, Yamada SD, Lindau ST
• Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
  American journal of respiratory and critical care medicine 2014 Todd JL, Wang X, Sugimoto S, Kennedy VE, Zhang HL, Pavlisko EN, Kelly FL, Huang H, Kreisel D, Palmer SM, Gelman AE
• Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013 Kennedy VE, Todd JL, Palmer SM
• Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012 Kelly FL, Kennedy VE, Jain R, Sindhwani NS, Finlen Copeland CA, Snyder LD, Eu JP, Meltzer EB, Brockway BL, Pavlisko E, Stripp BR, Palmer SM